4
Changes in Ownership
NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-22-005109
Director sold 15,000 shares at $74.43 ($1,116,378)
- Director acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
SHERWIN STEPHEN A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-24 | Exercise or conversion : show line 1 in the form | +15,000 | $6.66 | $99,900 | 40,055 | D |
| 2022-01-24 | Sale : show line 2 in the form | −15,000 | $74.43 | $1,116,378 | 25,055 | D |
| Open-market sales · 15,000 sh · avg $74.43 · $1,116,378 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-24 | Exercise or conversion : show line 3 in the form Non-Qualified Stock Option | −15,000 | $6.66 | $99,900 | 0 | D |
Loading xslF345X03/doc4.xml…